Early Effects of Treatment Low-dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction

Early Effects of Treatment Low-dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction

Dyslipidemia is one of the primary causes of cardiovascular disease. Therefore, attention has been focused on the development of drugs that normalize lipid levels and exert an effect on markers of atherothrombosis, insulin resistance (IR), and inflammation. Atorvastatin is a drug with not only lipid...

Full description

Bibliographic Details
Main Authors:	Olga Gruzdeva, Evgenya Uchasova, Yulia Dyleva, Olga Akbasheva, Victoria Karetnikova, Olga Barbarash
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-09-01
Series:	Frontiers in Pharmacology
Subjects:	Inflammation Myocardial Infarction Lipid statin Adipokine
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00324/full

Similar Items

Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
by: Gruzdeva O, et al.
Published: (2017-12-01)

Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study
by: Olga Barbarash, et al.
Published: (2017-01-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

RELATIONSHIP OF OBESITY PARAMETERS AND ADIPOKINES WITH THE RISK OF 2ND TYPE DIABETES DEVELOPMENT IN A YEAR AFTER MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-04-01)

CLINICAL AND BIOCHEMICAL PREDICTORS OF DIABETES MELLITUS MANIFESTATION AFTER MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2014-03-01)

Adipocytes Directly Affect Coronary Artery Disease Pathogenesis via Induction of Adipokine and Cytokine Imbalances
by: Olga Gruzdeva, et al.
Published: (2019-09-01)

Role of plasminogen activator inhibitor and free fatty acids in diagnosis of insulin resistance in patients with myocardial infarction
by: Olga Viktorovna Gruzdeva, et al.
Published: (2011-12-01)

CYTOKINE PROFILE IN VISCERAL OBESITY AND ADVERSE CARDIOVASCULAR PROGNOSIS OF MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-06-01)

Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction
by: Olga Gruzdeva, et al.
Published: (2018-03-01)

Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study
by: Celal Kilit, et al.
Published: (2017-04-01)

High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction
by: Gavazzoni M, et al.
Published: (2017-12-01)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
by: William T. Wang, et al.
Published: (2018-02-01)

INSULIN RESISTANCE MARKERS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2011-12-01)

Relationship between epicardial and perivascular fatty tissue and adipokine-cytokine level in coronary artery disease patients.
by: Olga Gruzdeva, et al.
Published: (2019-01-01)

Correlation of CCL18 with Levels of Adi-pokines in the Sera of Patients with Myocardial Infarction in a 6-Month Period: Case Series
by: Atefeh GamarTalepoor, et al.
Published: (2020-07-01)

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin
by: Celestino Sardu, et al.
Published: (2019-09-01)

Adipokines and Inflammatory Markers in Acute Myocardial Infarction Patients with and without Obstructive Sleep Apnea: A Comparative Analysis
by: Ana L. Vega-Jasso, et al.
Published: (2023-09-01)

Incidence, Predictors and Outcomes of Subacute Stent Thrombosis following Primary Stenting for ST-elevation Myocardial Infarction
by: Su-Kiat Chua, et al.
Published: (2010-06-01)

Efficacy of Statin Treatment According to Baseline Renal Function in Korean Patients with Acute Myocardial Infarction Not Requiring Dialysis Undergoing Newer-Generation Drug-Eluting Stent Implantation
by: Yong Hoon Kim, et al.
Published: (2021-08-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-07-01)

Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality
by: Leili Pourafkari, et al.
Published: (2016-03-01)

Localization of fat depots and cardiovascular risk
by: Olga Gruzdeva, et al.
Published: (2018-09-01)

Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction.
by: Victoria Karetnikova, et al.
Published: (2017-01-01)

Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction
by: Tamara Pecherina, et al.
Published: (2020-05-01)

Effect of atorvastatin on the most important mechanisms of arrhythmogenesis in patients with ST-elevated myocardial infarction
by: V. E. Oleynikov, et al.
Published: (2019-08-01)

COMPARISON OF IN-HOSPITAL LETHALITY PROGNOSTIC SCALES IN MYOCARDIAL INFARCTION PATIENTS
by: M. V. Zykov, et al.
Published: (2012-02-01)

Statin Use in Cancer Patients with Acute Myocardial Infarction and Its Impact on Long-Term Mortality
by: Konrad Stepien, et al.
Published: (2022-07-01)

Renal dysfunction in patients with myocardial infarction concurrent with type 2 diabetes mellitus
by: M V Evseeva, et al.
Published: (2015-01-01)

The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction
by: Stella Trompet, et al.
Published: (2022-01-01)

A model for predicting acute heart failure in patients with acute myocardial infarction by taking into account energy and adipokine metabolism indicators
by: M.Yu. Koteliukh
Published: (2022-09-01)

Selecting of statins optimum dosage regimen in patients with acute Q-wave myocardial infarction after thrombolytic therapy
by: V. D. Syvolap, et al.
Published: (2014-04-01)

Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
by: Soichiro Ebisawa, et al.
Published: (2015-09-01)

Statin Eligibility and Outpatient Care Prior to ST‐Segment Elevation Myocardial Infarction
by: Michael D. Miedema, et al.
Published: (2017-04-01)

Patient after myocardial infarction: how to reduce the risk of recurrent ischemic events?
by: O. L Barbarash, et al.
Published: (2015-06-01)

ROLE OF THE SERUM NGAL FOR ASSESSMENT OF HOSPITAL PROGNOSIS IN MEN WITH ST ELEVATION MYOCARDIAL INFARCTION
by: V. N. Karetnikova, et al.
Published: (2015-06-01)

Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study
by: Yong Hoon Kim, et al.
Published: (2021-08-01)

Effect of Very Early Atorvastatin Initiation for Acute Myocardial Infarction on Creatine Kinase release
by: Faris Abdul Kareem, et al.
Published: (2010-06-01)

SPECIAL FEATURES OF REHABILITATION AND OUTCOME PREDICTION IN MYOCARDIAL INFARCTION COMPLICATED BY ARRHYTHMIAS
by: N. I. Tarasov, et al.
Published: (2001-06-01)

Analysis of Serum Lipid Level and Drug Use in Patients with Acute Myocardial Infarction
by: LIU Chuanfen, LI Zheng, WU Manyan, CUI Yuxia, SONG Jing, ZHANG Chunying, CHEN Hong
Published: (2023-04-01)